Accès ouvert
2025
article
OpenAlex
Diya Surie, Wesley H. Self, Katharine A. Yuengling, Adam S. Lauring et autres
Importance: Respiratory syncytial virus (RSV) vaccines for adults aged 60 years or older became available in 2023. One dose is recommended for all adults aged 75 years or older and those aged 60 to 74 years at increased risk of severe RSV; …
us
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Nathaniel M. Lewis, Elizabeth Harker, Lauren Grant, Yuwei Zhu et autres
BACKGROUND: Clinical guidelines recommend initiation of antiviral therapy as soon as possible for patients hospitalized with confirmed or suspected influenza. METHODS: A multicenter US observational sentinel surveillance network prospectively enrolled adults (aged ≥18 years) hospitalized with laboratory-confirmed influenza at 24 hospitals during …
us
(code pays fourni par la source)
Accès ouvert
2024
preprint
OpenAlex
James Hollister, Cynthia Porter, Ryan Sprissler, Shawn C. Beitel et autres
Abstract The extent to which semi-quantitative antibody levels confer protection against SARS-CoV-2 infection in populations with heterogenous immune histories is unclear. Two nested case-control studies were designed within the multisite HEROES/RECOVER prospective cohort of frontline workers to study the relationship between antibody …
us
(code pays fourni par la source)